Judge strikes down Obamacare coverage of preventive care for cancers, diabetes, HIV and other conditions

Judge strikes down Obamacare coverage of preventive care for cancers, diabetes, HIV and other conditions


A consultant analyzing a mammogram.

Rui Vieira | PA Wire | Getty Images

A federal judge on Thursday struck down an Obamacare mandate that required most private health insurance plans to cover preventive care such as certain cancer screenings and HIV prevention drugs.

These services included screenings for breast, cervical and lung cancers; tests for sexually transmitted infections; as well as coverage of drugs that prevent HIV infection in high risk populations, called pre-exposure prophylaxis or PrEP.

You can find the full list of covered preventive services the judge struck down here.

Judge Reed O’Connor in U.S. Northern District of Texas struck down those coverage requirements and blocked the federal government from enforcing them. The Biden administration is likely to appeal the ruling.

The Department of Health and Human Services did not immediately respond to a request to comment.

The Affordable Care Act mandated free coverage of health services recommended by an independent panel of experts called the Preventive Services Task Force. O’Connor said that these coverage requirements are unconstitutional because the task force’s members were not nominated by the president and confirmed by the Senate, according to his opinion.

Two Christian businesses and several individuals sued the federal government in 2020, arguing that the preventive care mandate violates their religious freedom because it includes coverage of PrEP drugs that prevent HIV infection.

They claimed the mandate violated their religious beliefs by “making them complicit in facilitating homosexual behavior, drug use, and sexual activity outside of marriage between one man and one woman,” according to court documents.

They had also sought to overturn the federal mandate that requires Obamacare compliant plans to cover birth control with no out-of-pocket costs. O’Connor ruled against those claims and kept the contraception mandate in place.

This is a developing story. Please check back for updates.

CNBC Health & Science

Read CNBC’s latest global health coverage:



Source

Candy giant Mars partners with biotech firm to gene-edit cocoa supply
Health

Candy giant Mars partners with biotech firm to gene-edit cocoa supply

Packages of M&M’s milk chocolate candy are stacked at a Costco Wholesale store on July 12, 2025 in San Diego, California. Kevin Carter | Getty Images News | Getty Images Candy maker Mars said Wednesday it’s partnered with biotech company Pairwise to speed up the development of more resilient cocoa using CRISPR-based gene editing technology. […]

Read More
Healthy Returns: Medicare, Medicaid will reportedly pilot covering obesity drugs – a potential win for drugmakers
Health

Healthy Returns: Medicare, Medicaid will reportedly pilot covering obesity drugs – a potential win for drugmakers

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. For […]

Read More
Hinge Health stock pops 6% after first quarterly report since IPO
Health

Hinge Health stock pops 6% after first quarterly report since IPO

Hinge Health co-founders, Gabriel Mecklenburg and Daniel Perez celebrate its initial public offering at the New York Stock Exchange on May 22, 2025. NYSE Shares of Hinge Health popped 6% in extended trading on Tuesday after the digital physical therapy company reported quarterly results for the first time since its debut on the New York […]

Read More